Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals, Inc. (SPPI) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SPPI · as of Jun 9, 2026
Key Statistics
Explore Spectrum Pharmaceuticals, Inc. Data
sppi stock data · financialsAnalyst Ratings & Price Target
Full ForecastTotal: 14 · Buy rate: 42.9%
The SPPI analyst consensus is Hold, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month price target is $0.75, representing -26.83% downside from the current price of $1.02.
Competitors & Peers
sppi competitorsSPPI
CRGX
INZY
LENZ
LSB
SLRNAbout Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals, Inc. operates as a biopharmaceutical firm, primarily engaged in the research, development, and market introduction of innovative drug products for cancer and blood disorders.…
what is spectrum pharmaceuticals, inc. · sppi stock overview · spectrum pharmaceuticals, inc. company profile · who is spectrum pharmaceuticals, inc. ceo · sppi NASDAQ · spectrum pharmaceuticals, inc. headquarters · spectrum pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Spectrum Pharmaceuticals, Inc. (SPPI) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 26, 1996. As of the latest trading session, SPPI stock price is $1.02, with a market capitalization of $210.4M. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Spectrum Pharmaceuticals, Inc. (SPPI) stock price is $1.02. The stock is traded on NASDAQ under the ticker symbol SPPI. The 52-week range is $0.32 – $1.57.